Serina Therapeutics, Inc.
SER
$3.79
-$0.02-0.53%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.59M | -6.45M | -4.81M | -2.74M | 1.41M |
| Total Depreciation and Amortization | 16.00K | 16.00K | 17.00K | 56.00K | 56.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 8.00K | 8.00K |
| Total Other Non-Cash Items | -677.00K | 1.98M | 19.00K | -1.74M | -5.54M |
| Change in Net Operating Assets | 1.40M | 706.00K | 455.00K | -172.00K | 1.11M |
| Cash from Operations | -3.85M | -3.75M | -4.32M | -4.59M | -2.96M |
| Capital Expenditure | -13.00K | -46.00K | -- | -5.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.00K | -46.00K | -- | -5.00K | -3.00K |
| Total Debt Issued | 4.91M | -- | -- | 110.00K | 8.00K |
| Total Debt Repaid | -- | -- | -- | -1.00K | -8.00K |
| Issuance of Common Stock | 1.53M | 630.00K | 1.00K | 4.92M | 86.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 4.94M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 4.92M | 0.00 | 0.00 |
| Cash from Financing | 6.44M | 5.57M | 4.92M | 5.03M | 86.00K |
| Foreign Exchange rate Adjustments | -2.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.58M | 1.77M | 595.00K | 437.00K | -2.88M |